Aggrenox To Treat Acute Covid-19
Condition:   Covid19 Interventions:   Drug: Dipyridamole ER 200mg/ Aspirin 25mg orally/enterally;   Other: Standard of care Sponsors:   Rutgers, The State University of New Jersey;   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2020 Category: Research Source Type: clinical trials

Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH
Condition:   HealthyInterventions:   Drug: Aggrenox;   Drug: Dipyridamole;   Drug: Aspirin;   Drug: LansoprazoleSponsor:   Boehringer IngelheimCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2014 Category: Research Source Type: clinical trials

Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)
Condition:   Systemic Lupus ErythematosusInterventions:   Drug: extended release dipyridamole 200mg/aspirin 25mg;   Drug: 81mg aspirinSponsors:   Oklahoma Medical Research Foundation;   Oklahoma Rheumatic Disease Research Cores CenterActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2013 Category: Research Source Type: clinical trials

Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)
Condition:   Systemic Lupus ErythematosusInterventions:   Drug: extended release dipyridamole 200mg/aspirin 25mg;   Drug: 81mg aspirinSponsors:   Oklahoma Medical Research Foundation;   Oklahoma Medical Research Foundation;   Oklahoma Rheumatic Disease Research Cores CenterRecruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 2, 2013 Category: Research Source Type: clinical trials

Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)
Condition:   Systemic Lupus ErythematosusInterventions:   Drug: extended release dipyridamole 200mg/aspirin 25mg;   Drug: 81mg aspirinSponsors:   Oklahoma Medical Research Foundation;   Oklahoma Rheumatic Disease Research Cores CenterRecruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 2, 2013 Category: Research Source Type: clinical trials

JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme
Condition:   Cerebrovascular AccidentInterventions:   Drug: Aggrenox capsule;   Other: Acetylsalicylic Acid (ASA)Sponsor:   Boehringer IngelheimCompleted - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2006 Category: Research Source Type: clinical trials

Treatment of Supine Hypertension in Autonomic Failure
Condition:   HypertensionInterventions:   Drug: Clonidine;   Drug: Nitroglycerin transdermal;   Drug: Dipyridamole/ Aspirin (Aggrenox);   Drug: Desmopressin (DDAVP);   Drug: Sildenafil;   Drug: Nifedipine;   Drug: Hydralazine;   Drug: Hydrochlorothiazide;   Drug: Placebo;   Drug: Bosentan;   Drug: Diltiazem;   Drug: Eplerenone;   Drug: guanfacine;   Dietary Supplement: L-arginine;   Drug: captopril;   Drug: carbidopa;   Drug: ...
Source: ClinicalTrials.gov - September 21, 2005 Category: Research Source Type: clinical trials

Treatment of Supine Hypertension in Autonomic Failure
Condition:   HypertensionInterventions:   Drug: Clonidine;   Drug: Nitroglycerin transdermal;   Drug: Dipyridamole/ Aspirin (Aggrenox);   Drug: Desmopressin (DDAVP);   Drug: Sildenafil;   Drug: Nifedipine;   Drug: Hydralazine;   Drug: Hydrochlorothiazide;   Drug: Placebo;   Drug: Bosentan;   Drug: Diltiazem;   Drug: Eplerenone;   Drug: guanfacine;   Dietary Supplement: L-arginine;   Drug: captopril;   Drug: carbidopa;   Drug: ...
Source: ClinicalTrials.gov - September 14, 2005 Category: Research Source Type: clinical trials

Treatment of Supine Hypertension in Autonomic Failure
Condition:   HypertensionInterventions:   Drug: Clonidine;   Drug: Nitroglycerin transdermal;   Drug: Dipyridamole/ Aspirin (Aggrenox);   Drug: Desmopressin (DDAVP);   Drug: Sildenafil;   Drug: Nifedipine;   Drug: Hydralazine;   Drug: Hydrochlorothiazide;   Drug: Placebo;   Drug: Bosentan;   Drug: Diltiazem;   Drug: Eplerenone;   Drug: guanfacine;   Dietary Supplement: L-arginine;   Drug: captopril;   Drug: carbidopa;   Drug: ...
Source: ClinicalTrials.gov - September 14, 2005 Category: Research Source Type: clinical trials